Table 1 Clinical parameters between Bakri balloon group vs control group
From: Menstrual and reproductive outcomes after use of balloon tamponade for severe postpartum hemorrhage
Bakri balloon only (n = 39) | Control (n = 161) | p-value; MD; (95% CI) | |
|---|---|---|---|
Maternal age (years) | 33.9 (4.00) | 34.6 (4.98) | 0.442; − 0.66 (−2.35 to 1.03) |
Gestation at delivery (weeks) | 38.1 (2.07) | 38.3 (2.43) | 0.78; −0.12 (− 0.95 to 0.71) |
Parity | |||
Primiparous | 19 (48.7%) | 71 (44.1%) | 0.60 |
Multiparous | 20 (51.3%) | 90 (55.9%) | |
Multiple pregnancy | 7 (17.9%) | 17 (10.6%) | 0.27 |
Previous caesarean section | 5 (12.8%) | 52 (32.3%) | *0.02 |
Mode of delivery | |||
Normal vaginal | 9 (23.1%) | 27 (16.8%) | 0.56 |
Instrumental | 1 (2.6%) | 8 (5.0%) | |
Caesarean section | 29 (74.3%) | 126 (78.3%) | |
Cause of severe PPH | |||
Uterine atony | 24 (61.5%) | 115 (71.4%) | 0.38 |
Placenta praevia/accreta | 12 (30.8%) | 33 (20.5%) | |
Genital tract trauma | 3 (7.7%) | 13 (8.1%) | |
Total blood loss (ml) | 1812 (748) | 1440 (413) | *< 0.001; 371 (197 to 545) |
Blood product transfusion | 35 (89.7%) | 91 (56.5%) | *< 0.001 |
Coagulopathy | 11 (28.2%) | 34 (21.1%) | 0.34 |
Presence of endometritis after delivery | 1 (2.6%) | 3 (1.9%) | 0.583 |